カテゴリー： 9Dimen Research, 世界, 医療/バイオ

世界の腫瘍/がん治療薬市場2023-2027

◆英語タイトル：Global Oncology/Cancer Drugs Market Research Report 2023-2027

9Dimen Researchが発行した調査報告書（DMN23J1337）◆商品コード：DMN23J1337
◆発行会社（リサーチ会社）：9Dimen Research
◆発行日：2023年7月
◆ページ数：158
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,200 ⇒換算￥480,000見積依頼/購入/質問フォーム
Global/Corporate User（法人閲覧用）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

米中貿易戦争、ロシア・ウクライナ戦争、世界経済の不安定性と不確実性は世界の腫瘍/がん治療薬市場に大きな影響を与えるでしょう。腫瘍/がん治療薬市場レポートは、主要地域（北アメリカ、ヨーロッパ、アジア太平洋）と主要国（アメリカ、ドイツ、英国、日本、韓国、中国）に焦点を当てた、世界の主要地域の市場状況に関する専門的かつ包括的な調査レポートです。このレポートでは、世界の腫瘍/がん治療薬市場規模は 2023年にXX百万ドルと評価され、2027年末までにXX百万ドルに達すると予測されており、2023年から2027年にかけてXX%のCAGRで成長すると予測されています。
本調査レポートに記載されている主要な企業は、Roche diagnostics、Novartis AG、Celgene Corporation、AstraZeneca、Johnson & Johnson、Merck & Co.、Eli Lilly & Co.、GlaxoSmithKlineなどです。

本レポートは、世界の腫瘍/がん治療薬市場（2023年-2027年）について調査・分析し、腫瘍/がん治療薬の世界市場規模、市場予測、市場動向、上流市場分析、下流市場分析、アジア市場動向、北アメリカ市場動向、ヨーロッパ市場動向、マーケティングチャネル分析、投資可能性分析、メーカー分析などの情報を掲載しています。また、種類別（化学療法、標的療法、免疫療法（生物学的療法）、ホルモン療法、……など）、用途別（血液がん、乳がん、消化器がん、前立腺がん、呼吸器・肺がん、皮膚がん、……など）のセグメント情報も収録しています。

・腫瘍/がん治療薬の市場概要
・腫瘍/がん治療薬の上流・下流市場分析
・腫瘍/がん治療薬のアジア市場：市場分析（製品開発、競争環境、市場動向等）
・腫瘍/がん治療薬のアジア市場：市場規模（生産規模、市場シェア、需要、輸出・輸入等）
・腫瘍/がん治療薬のアジア市場：主要メーカー分析（製品、用途、生産量、価格、企業連絡先等）
・腫瘍/がん治療薬のアジア市場：市場予測（生産規模、市場シェア、需要、輸出・輸入等）
・腫瘍/がん治療薬の北アメリカ市場：市場分析（製品開発、競争環境、市場動向等）
・腫瘍/がん治療薬の北アメリカ市場：市場規模（生産規模、市場シェア、需要、輸出・輸入等）
・腫瘍/がん治療薬の北アメリカ市場：主要メーカー分析（製品、用途、生産量、価格、企業連絡先等）
・腫瘍/がん治療薬の北アメリカ市場：市場予測（生産規模、市場シェア、需要、輸出・輸入等）
・腫瘍/がん治療薬のヨーロッパ市場：市場分析（製品開発、競争環境、市場動向等）
・腫瘍/がん治療薬のヨーロッパ市場：市場規模（生産規模、市場シェア、需要、輸出・輸入等）
・腫瘍/がん治療薬のヨーロッパ市場：主要メーカー分析（製品、用途、生産量、価格、企業連絡先等）
・腫瘍/がん治療薬のヨーロッパ市場：市場予測（生産規模、市場シェア、需要、輸出・輸入等）
・腫瘍/がん治療薬のマーケティングチャネル分析
・マクロ経済分析（中国経済、ヨーロッパ経済、アメリカ経済、日本経済、グローバル経済）
・腫瘍/がん治療薬の投資可能性分析
・腫瘍/がん治療薬の世界市場規模（2018年-2023年推移、2023年-2027年予測）
...

Rising incidence of various cancer conditions, growing popularity of advance therapies (biological and targeted drug therapies), patents expiration of leading drugs along with commercialization of biosimilars are the few factors driving the growth of global oncology drugs market. In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Oncology/Cancer Drugs Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Oncology/Cancer Drugs market is valued at USD XX million in 2023 and is projected to reach USD XX million by the end of 2027, growing at a CAGR of XX% during the period 2023 to 2027.

The report firstly introduced the Oncology/Cancer Drugs basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:
Roche diagnostics
Novartis AG
Celgene Corporation
AstraZeneca
Johnson & Johnson
Merck & Co.
Eli Lilly & Co.
GlaxoSmithKline
……

The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
……

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Oncology/Cancer Drugs for each application, including-
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Skin Cancer
……

❖ レポートの目次 ❖

Table of Contents

Part I Oncology/Cancer Drugs Industry Overview

Chapter One Oncology/Cancer Drugs Industry Overview
1.1 Oncology/Cancer Drugs Definition
1.2 Oncology/Cancer Drugs Classification Analysis
1.2.1 Oncology/Cancer Drugs Main Classification Analysis
1.2.2 Oncology/Cancer Drugs Main Classification Share Analysis
1.3 Oncology/Cancer Drugs Application Analysis
1.3.1 Oncology/Cancer Drugs Main Application Analysis
1.3.2 Oncology/Cancer Drugs Main Application Share Analysis
1.4 Oncology/Cancer Drugs Industry Chain Structure Analysis
1.5 Oncology/Cancer Drugs Industry Development Overview
1.5.1 Oncology/Cancer Drugs Product History Development Overview
1.5.1 Oncology/Cancer Drugs Product Market Development Overview
1.6 Oncology/Cancer Drugs Global Market Comparison Analysis
1.6.1 Oncology/Cancer Drugs Global Import Market Analysis
1.6.2 Oncology/Cancer Drugs Global Export Market Analysis
1.6.3 Oncology/Cancer Drugs Global Main Region Market Analysis
1.6.4 Oncology/Cancer Drugs Global Market Comparison Analysis
1.6.5 Oncology/Cancer Drugs Global Market Development Trend Analysis

Chapter Two Oncology/Cancer Drugs Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Oncology/Cancer Drugs Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Oncology/Cancer Drugs Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Oncology/Cancer Drugs Market Analysis
3.1 Asia Oncology/Cancer Drugs Product Development History
3.2 Asia Oncology/Cancer Drugs Competitive Landscape Analysis
3.3 Asia Oncology/Cancer Drugs Market Development Trend

Chapter Four 2018-2023 Asia Oncology/Cancer Drugs Productions Supply Sales Demand Market Status and Forecast
4.1 2018-2023 Oncology/Cancer Drugs Production Overview
4.2 2018-2023 Oncology/Cancer Drugs Production Market Share Analysis
4.3 2018-2023 Oncology/Cancer Drugs Demand Overview
4.4 2018-2023 Oncology/Cancer Drugs Supply Demand and Shortage
4.5 2018-2023 Oncology/Cancer Drugs Import Export Consumption
4.6 2018-2023 Oncology/Cancer Drugs Cost Price Production Value Gross Margin

Chapter Five Asia Oncology/Cancer Drugs Key Manufacturers Analysis
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
…
…
Chapter Six Asia Oncology/Cancer Drugs Industry Development Trend
6.1 2023-2027 Oncology/Cancer Drugs Production Overview
6.2 2023-2027 Oncology/Cancer Drugs Production Market Share Analysis
6.3 2023-2027 Oncology/Cancer Drugs Demand Overview
6.4 2023-2027 Oncology/Cancer Drugs Supply Demand and Shortage
6.5 2023-2027 Oncology/Cancer Drugs Import Export Consumption
6.6 2023-2027 Oncology/Cancer Drugs Cost Price Production Value Gross Margin

Part III North American Oncology/Cancer Drugs Industry (The Report Company Including the Below Listed But Not All)

Chapter Seven North American Oncology/Cancer Drugs Market Analysis
7.1 North American Oncology/Cancer Drugs Product Development History
7.2 North American Oncology/Cancer Drugs Competitive Landscape Analysis
7.3 North American Oncology/Cancer Drugs Market Development Trend

Chapter Eight 2018-2023 North American Oncology/Cancer Drugs Productions Supply Sales Demand Market Status and Forecast
8.1 2018-2023 Oncology/Cancer Drugs Production Overview
8.2 2018-2023 Oncology/Cancer Drugs Production Market Share Analysis
8.3 2018-2023 Oncology/Cancer Drugs Demand Overview
8.4 2018-2023 Oncology/Cancer Drugs Supply Demand and Shortage
8.5 2018-2023 Oncology/Cancer Drugs Import Export Consumption
8.6 2018-2023 Oncology/Cancer Drugs Cost Price Production Value Gross Margin

Chapter Nine North American Oncology/Cancer Drugs Key Manufacturers Analysis
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information
…
…
Chapter Ten North American Oncology/Cancer Drugs Industry Development Trend
10.1 2023-2027 Oncology/Cancer Drugs Production Overview
10.2 2023-2027 Oncology/Cancer Drugs Production Market Share Analysis
10.3 2023-2027 Oncology/Cancer Drugs Demand Overview
10.4 2023-2027 Oncology/Cancer Drugs Supply Demand and Shortage
10.5 2023-2027 Oncology/Cancer Drugs Import Export Consumption
10.6 2023-2027 Oncology/Cancer Drugs Cost Price Production Value Gross Margin

Part IV Europe Oncology/Cancer Drugs Industry Analysis (The Report Company Including the Below Listed But Not All)

Chapter Eleven Europe Oncology/Cancer Drugs Market Analysis
11.1 Europe Oncology/Cancer Drugs Product Development History
11.2 Europe Oncology/Cancer Drugs Competitive Landscape Analysis
11.3 Europe Oncology/Cancer Drugs Market Development Trend

Chapter Twelve 2018-2023 Europe Oncology/Cancer Drugs Productions Supply Sales Demand Market Status and Forecast
12.1 2018-2023 Oncology/Cancer Drugs Production Overview
12.2 2018-2023 Oncology/Cancer Drugs Production Market Share Analysis
12.3 2018-2023 Oncology/Cancer Drugs Demand Overview
12.4 2018-2023 Oncology/Cancer Drugs Supply Demand and Shortage
12.5 2018-2023 Oncology/Cancer Drugs Import Export Consumption
12.6 2018-2023 Oncology/Cancer Drugs Cost Price Production Value Gross Margin

Chapter Thirteen Europe Oncology/Cancer Drugs Key Manufacturers Analysis
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information
…
…
Chapter Fourteen Europe Oncology/Cancer Drugs Industry Development Trend
14.1 2023-2027 Oncology/Cancer Drugs Production Overview
14.2 2023-2027 Oncology/Cancer Drugs Production Market Share Analysis
14.3 2023-2027 Oncology/Cancer Drugs Demand Overview
14.4 2023-2027 Oncology/Cancer Drugs Supply Demand and Shortage
14.5 2023-2027 Oncology/Cancer Drugs Import Export Consumption
14.6 2023-2027 Oncology/Cancer Drugs Cost Price Production Value Gross Margin

Part V Oncology/Cancer Drugs Marketing Channels and Investment Feasibility

Chapter Fifteen Oncology/Cancer Drugs Marketing Channels Development Proposals Analysis
15.1 Oncology/Cancer Drugs Marketing Channels Status
15.2 Oncology/Cancer Drugs Marketing Channels Characteristic
15.3 Oncology/Cancer Drugs Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals

Chapter Sixteen Development Environmental Analysis
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis

Chapter Seventeen Oncology/Cancer Drugs New Project Investment Feasibility Analysis
17.1 Oncology/Cancer Drugs Market Analysis
17.2 Oncology/Cancer Drugs Project SWOT Analysis
17.3 Oncology/Cancer Drugs New Project Investment Feasibility Analysis

Part VI Global Oncology/Cancer Drugs Industry Conclusions

Chapter Eighteen 2018-2023 Global Oncology/Cancer Drugs Productions Supply Sales Demand Market Status and Forecast
18.1 2018-2023 Oncology/Cancer Drugs Production Overview
18.2 2018-2023 Oncology/Cancer Drugs Production Market Share Analysis
18.3 2018-2023 Oncology/Cancer Drugs Demand Overview
18.4 2018-2023 Oncology/Cancer Drugs Supply Demand and Shortage
18.5 2018-2023 Oncology/Cancer Drugs Import Export Consumption
18.6 2018-2023 Oncology/Cancer Drugs Cost Price Production Value Gross Margin

Chapter Nineteen Global Oncology/Cancer Drugs Industry Development Trend
19.1 2023-2027 Oncology/Cancer Drugs Production Overview
19.2 2023-2027 Oncology/Cancer Drugs Production Market Share Analysis
19.3 2023-2027 Oncology/Cancer Drugs Demand Overview
19.4 2023-2027 Oncology/Cancer Drugs Supply Demand and Shortage
19.5 2023-2027 Oncology/Cancer Drugs Import Export Consumption
19.6 2023-2027 Oncology/Cancer Drugs Cost Price Production Value Gross Margin

Chapter Twenty Global Oncology/Cancer Drugs Industry Research Conclusions



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の腫瘍/がん治療薬市場2023-2027(Global Oncology/Cancer Drugs Market Research Report 2023-2027)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の卵巣がん治療薬市場2023-2027
  • 世界の腫瘍アブレーション治療市場2023-2027
  • 世界の放射線腫瘍学市場2023-2027
  • 世界の抗てんかん薬市場2023-2027
  • 世界のジェネリック医薬品市場2023-2027

    • ◆H&Iグローバルリサーチのお客様（例）◆